This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chesnokova, V. Articles by Melmed, S. Search for Related Content PubMed PubMed Citation Articles by Chesnokova, V. Articles by Melmed, S.

Murine Leukemia Inhibitory Factor Gene Disruption Attenuates the Hypothalamo-Pituitary-Adrenal Axis Stress Response¹

Division of Endocrinology and Metabolism, Cedars-Sinai Research Institute, University of California School of Medicine, Los Angeles, California 90048

Address all correspondence and requests for reprints to: Shlomo Melmed, M.D., Division of Endocrinology and Metabolism, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, B-131, Los Angeles, California 90048. E-mail: melmed{at}cshs.org

Recently, we have shown that human fetal pituitary, mouse corticotroph AtT20 cells, and murine hypothalamus and pituitary express leukemia inhibitory factor (LIF). LIF knockout mice (LIFKO), heterozygous and wild type (wt), of B6D2F1 genetic background were used to examine whether LIF may play a role in the regulation of the hypothalamo-pituitary-adrenal axis in vivo. Resting levels of plasma ACTH and corticosterone were similar in all three genotypes. However, LIFKO mice did not respond to 30-min restraint and 45-min immobilization stress with increased plasma ACTH. Increased circulating ACTH was only observed in LIFKO mice after very short immobilization stress (15 min), but this ACTH level was lower than in wt animals (P < 0.05). Injection of mycobacterial adjuvant resulted in a 2-fold increase of corticosterone levels 7 days after treatment in wt, but not LIFKO, mice (P < 0.05). Pituitary POMC messenger RNA (mRNA) levels were very low in LIFKO animals. Although 15 and 45 min of immobilization stress resulted in enhanced POMC mRNA content in all three groups, this elevation was lowest in LIFKO mice. Injection of 12 µg murine LIF to LIFKO and normal C57BL/6 animals resulted in increased plasma ACTH and corticosterone levels and elevated pituitary POMC mRNA levels in both LIF-repleted and LIF-depleted mice. Thus, LIF appears to play an important role in activating the hypothalamo-pituitary-adrenal axis during stress and inflammation.

This article has been cited by other articles:

				J. Gerez, J. Bonfiglio, S. Sosa, D. Giacomini, M. Acuna, A. Carbia Nagashima, M. J. Perone, S. Silberstein, U. Renner, G. K. Stalla, et al. Molecular transduction mechanisms of cytokine-hormone interactions: role of gp130 cytokines Exp Physiol, September 1, 2007; 92(5): 801 - 806. [Abstract] [Full Text] [PDF]

				O. Latchoumanin, V. Mynard, J. Devin-Leclerc, M.-A. Dugue, X. Bertagna, and M. G. Catelli Reversal of Glucocorticoids-Dependent Proopiomelanocortin Gene Inhibition by Leukemia Inhibitory Factor Endocrinology, January 1, 2007; 148(1): 422 - 432. [Abstract] [Full Text] [PDF]

				B. Emery, H. S. Cate, M. Marriott, T. Merson, M. D. Binder, C. Snell, P. Y. Soo, S. Murray, B. Croker, J.-G. Zhang, et al. Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination PNAS, May 16, 2006; 103(20): 7859 - 7864. [Abstract] [Full Text] [PDF]

				L. Robb, K. Boyle, S. Rakar, L. Hartley, J. Lochland, A. W. Roberts, W. S. Alexander, and D. Metcalf Genetic reduction of embryonic leukemia-inhibitory factor production rescues placentation in SOCS3-null embryos but does not prevent inflammatory disease PNAS, November 8, 2005; 102(45): 16333 - 16338. [Abstract] [Full Text] [PDF]

				A. Kariagina, S. Zonis, M. Afkhami, D. Romanenko, and V. Chesnokova Leukemia inhibitory factor regulates glucocorticoid receptor expression in the hypothalamic-pituitary-adrenal axis Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E857 - E863. [Abstract] [Full Text] [PDF]

				R. A. Abbud, R. Kelleher, and S. Melmed Cell-Specific Pituitary Gene Expression Profiles after Treatment with Leukemia Inhibitory Factor Reveal Novel Modulators for Proopiomelanocortin Expression Endocrinology, February 1, 2004; 145(2): 867 - 880. [Abstract] [Full Text] [PDF]

				A. Kariagina, D. Romanenko, S.-G. Ren, and V. Chesnokova Hypothalamic-Pituitary Cytokine Network Endocrinology, January 1, 2004; 145(1): 104 - 112. [Abstract] [Full Text] [PDF]

				A. Beishuizen and L. G. Thijs Review: Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis Innate Immunity, February 1, 2003; 9(1): 3 - 24. [Abstract] [PDF]

				A. Ben-Shlomo, I. Miklovsky, S.-G. Ren, W. H. Yong, A. P. Heaney, M. D. Culler, and S. Melmed Leukemia Inhibitory Factor Regulates Prolactin Secretion in Prolactinoma and Lactotroph Cells J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 858 - 863. [Abstract] [Full Text] [PDF]

				O. A. Tjurmina, I. Armando, J. M. Saavedra, D. S. Goldstein, and D. L. Murphy Exaggerated Adrenomedullary Response to Immobilization in Mice with Targeted Disruption of the Serotonin Transporter Gene Endocrinology, December 1, 2002; 143(12): 4520 - 4526. [Abstract] [Full Text] [PDF]

				C. Bousquet, V. Chesnokova, A. Kariagina, A. Ferrand, and S. Melmed cAMP Neuropeptide Agonists Induce Pituitary Suppressor of Cytokine Signaling-3: Novel Negative Feedback Mechanism for Corticotroph Cytokine Action Mol. Endocrinol., November 1, 2001; 15(11): 1880 - 1890. [Abstract] [Full Text] [PDF]

				V. Chesnokova and S. Melmed Leukemia Inhibitory Factor Mediates the Hypothalamic Pituitary Adrenal Axis Response to Inflammation Endocrinology, November 1, 2000; 141(11): 4032 - 4040. [Abstract] [Full Text] [PDF]

				J. Schwartz Intercellular Communication in the Anterior Pituitary Endocr. Rev., October 1, 2000; 21(5): 488 - 513. [Abstract] [Full Text]

				A. Slominski, J. Wortsman, T. Luger, R. Paus, and S. Solomon Corticotropin Releasing Hormone and Proopiomelanocortin Involvement in the Cutaneous Response to Stress Physiol Rev, July 1, 2000; 80(3): 979 - 1020. [Abstract] [Full Text] [PDF]

				C. J. Auernhammer and S. Melmed Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine Function Endocr. Rev., June 1, 2000; 21(3): 313 - 345. [Abstract] [Full Text]

				B. P. Haines, R. B. Voyle, and P. D. Rathjen Intracellular and Extracellular Leukemia Inhibitory Factor Proteins Have Different Cellular Activities That Are Mediated by Distinct Protein Motifs Mol. Biol. Cell, April 1, 2000; 11(4): 1369 - 1383. [Abstract] [Full Text]

				H. M. Hermanns, S. Radtke, C. Haan, H. Schmitz-Van de Leur, J. Tavernier, P. C. Heinrich, and I. Behrmann Contributions of Leukemia Inhibitory Factor Receptor and Oncostatin M Receptor to Signal Transduction in Heterodimeric Complexes with Glycoprotein 130 J. Immunol., December 15, 1999; 163(12): 6651 - 6658. [Abstract] [Full Text] [PDF]

				R. A. Gadient and P. H. Patterson Leukemia Inhibitory Factor, Interleukin 6, and Other Cytokines Using the GP130 Transducing Receptor: Roles in Inflammation and Injury Stem Cells, May 1, 1999; 17(3): 127 - 137. [Abstract] [Full Text]

				C. Bousquet and S. Melmed Critical Role for STAT3 in Murine Pituitary Adrenocorticotropin Hormone Leukemia Inhibitory Factor Signaling J. Biol. Chem., April 16, 1999; 274(16): 10723 - 10730. [Abstract] [Full Text] [PDF]

				B. P. Haines, R. B. Voyle, T. A. Pelton, R. Forrest, and P. D. Rathjen Complex Conserved Organization of the Mammalian Leukemia Inhibitory Factor Gene: Regulated Expression of Intracellular and Extracellular Cytokines J. Immunol., April 15, 1999; 162(8): 4637 - 4646. [Abstract] [Full Text] [PDF]

				H. Yano, C. Readhead, M. Nakashima, S.-G. Ren, and S. Melmed Pituitary-Directed Leukemia Inhibitory Factor Transgene Causes Cushing's Syndrome: Neuro-Immune-Endocrine Modulation of Pituitary Development Mol. Endocrinol., November 1, 1998; 12(11): 1708 - 1720. [Abstract] [Full Text]

				Z. Wang and S. Melmed Functional Map of a Placenta-specific Enhancer of the Human Leukemia Inhibitory Factor Receptor Gene J. Biol. Chem., October 2, 1998; 273(40): 26069 - 26077. [Abstract] [Full Text] [PDF]

				C. J. Auernhammer, V. Chesnokova, C. Bousquet, and S. Melmed Pituitary Corticotroph SOCS-3: Novel Intracellular Regulation of Leukemia-Inhibitory Factor-Mediated Proopiomelanocortin Gene Expression and Adrenocorticotropin Secretion Mol. Endocrinol., July 1, 1998; 12(7): 954 - 961. [Abstract] [Full Text]

				S. Reichlin Editorial: What's In a Name or What Does Leukemia Inhibitory Factor Have to Do with the Pituitary Gland? Endocrinology, May 1, 1998; 139(5): 2199 - 2200. [Full Text] [PDF]

				C. J. Auernhammer, V. Chesnokova, and S. Melmed Leukemia Inhibitory Factor Modulates Interleukin-1{beta}-Induced Activation of the Hypothalamo-Pituitary-Adrenal Axis Endocrinology, May 1, 1998; 139(5): 2201 - 2208. [Abstract] [Full Text] [PDF]

				V. Chesnokova, A. Kariagina, and S. Melmed Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation Am J Physiol Endocrinol Metab, May 1, 2002; 282(5): E1110 - E1118. [Abstract] [Full Text] [PDF]